Insmed Inc $12.67

up +0.14


17/4/2014 12:25 PM  |  NASDAQ : INSM  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INSM Trend Analysis - it has outperformed the S&P 500 by 47%

Partner Headlines

  1. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares ...

    Benzinga
  2. Mid-Day Market Update: Nordion Surges On Acquisition News; BlackBerry Shares ...

    Benzinga
  3. Insmed falls on mixed results

    IBD
  4. Market Wrap For March 26: Markets Close Near Session Lows In Yet Another ...

    Benzinga
  5. Insmed Falls On Mixed Results For Lung Drug

    IBD
  6. Morning Market Losers

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. UPDATE: Insmed Says Arikayce Did Not Meet Pre-Specified Level for Statistical ...

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. Benzinga's Top #PreMarket Losers

    Benzinga
  11. UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector ...

    Benzinga
  12. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress ...

    Benzinga
  13. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga
  14. Insmed Reports Issuance of Two Patents

    Benzinga
  15. Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks

    Benzinga
  16. Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

    GuruFocus
  17. Insmed Names Lewis CEO

    Benzinga
  18. Insmed Inc. Reports Operating Results (10-Q)

    GuruFocus
  19. Insmed up 12% After Insider Share Purchase

    Benzinga
  20. Insmed Provides Corporate Update; Projects Cash Sufficient to Generate ...

    Benzinga
  21. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical ...

    Benzinga
  22. Insmed Skyrockets 70% after FDA Lifts Clinical Hold

    Benzinga
  23. Benzinga's Microcap Movers for Friday January 20, 2012

    Benzinga
  24. Insmed Surges after Clinical Hold Lifted by FDA

    Benzinga
Trading Center